Rivian raises 2026 delivery outlook while Lucid misses Wall Street expectations for second quarter

Rivian Automotive has lifted its delivery forecast for the year, telling investors it now expects to hand over between 65,000 and 70,000 electric vehicles in 2026, an upgrade from the 62,000-to-67,000 range it had previously projected. The revision, disclosed alongside second-quarter results, signals that the Irvine, California-based automaker is seeing sturdier demand for its R1 series trucks and SUVs than it had anticipated earlier this year.
The improved guidance stands out at a moment when much of the electric-vehicle sector is grappling with softer consumer appetite, higher interest rates weighing on financing costs, and the phaseout of federal purchase incentives that had once made EVs more affordable. Rivian's ability to raise rather than trim its outlook suggests the company is finding pockets of resilient buyer interest even as rivals struggle.
That contrast was made plain by Lucid Group, which reported second-quarter results falling short of what analysts on Wall Street had penciled in. The Newark, California-based luxury EV maker, known for its Air sedan and Gravity SUV, did not match consensus projections for the period, underscoring the uneven trajectory among newer entrants competing against both legacy automakers and Tesla in the battery-electric space.
Rivian's climb has been years in the making. Backed early on by Amazon and Ford, the company built its reputation on adventure-oriented trucks and delivery vans before expanding its consumer lineup. Steadier production lines and fewer supply-chain disruptions this year appear to have helped the automaker convert order backlogs into actual deliveries at a faster clip than management had modeled when it issued its original 2026 guidance.
Lucid, by comparison, has leaned on backing from Saudi Arabia's Public Investment Fund to sustain production while it works to broaden its customer base beyond a niche luxury audience. Its higher price points have made the company more exposed to shifts in high-end consumer spending, and slower-than-expected sales have repeatedly forced it to recalibrate output targets in recent years.
The divergence between the two companies carries implications for how investors judge the broader EV market. Rather than a uniform slowdown, the latest results point to a bifurcated landscape in which vehicle lineup, price positioning, and brand appeal are determining which automakers can still grow deliveries and which are falling behind projections.
Analysts will be watching whether Rivian can sustain the pace needed to hit the upper end of its new 65,000-to-70,000 range over the back half of the year, particularly as competition intensifies and incentive programs continue to shift. For Lucid, the pressure now shifts to its remaining quarters, with investors likely to scrutinize any updated production or delivery targets for signs of whether the shortfall was a temporary stumble or a sign of deeper demand problems.
Neither company immediately detailed how broader economic conditions, including borrowing costs and any changes to consumer EV credits, factored into their latest projections, leaving open questions about how much of the divide reflects company-specific execution versus industry-wide headwinds.
Source: CNBC Business
Related articles
Why a hidden divergence between the VIX and Nasdaq volatility has the smart money on edge
Traders are completely enthralled by the bull market — but surging Nasdaq volatility suggests it is time to hedge.
Create AI images with your own API key
aixipi runs on desktop/web, uses your own model API balance, and avoids subscription lock-in.
Try aixipi →When it comes to beating the stock market, no news really is good news
A new study has found a flaw in how people interpret the very headlines they are seeing.
Before you max out your 401(k) this year, consider a much better use for your next paycheck
Grabbing an employer match is essential, but prioritizing high-interest debt and emergency cash can bring much better near-term results.